Public Accounts committee  Thank you for your question. Perhaps it would be better to ask my counterparts, Mr. Sargent and Mr. Smith.

Public Accounts committee  Good morning and thank you, Madam Chair. I am pleased to join my colleagues to speak to the committee as it studies the Auditor General's 2021 report on the national shipbuilding strategy. Despite the global pandemic, Public Services and Procurement Canada continues its importan

Health committee  Thank you, Iain and Mr. Chair. I'll be very quick here on this front. Iain is bang on in terms of what Madam Brodie spoke to. The question mark is, what will Moderna deliver in June? As I mentioned in response to a previous question, we will have clarity on that in the next week

Health committee  Thank you, Iain. Mr. Chair, the only thing I would add is that the next shipment of AstraZeneca, should it be necessary, would likely be in the last week of June, and we'll play that by ear based on demand from provinces. We do have enough Pfizer and Moderna on order in case p

Health committee  There are a couple of comments to make on this, Mr. Chair. We are negotiating for 2022 and beyond, and we've had some work done there already. There are considerations here in terms of additional transparency, and we're working through right now with our suppliers what transpare

Health committee  I think there are a couple of points here. Especially early on, Mr. Chair, when we were negotiating these a year ago, the suppliers were very much.... It was a non-starter, frankly, when we talked about transparency, and we do have some ongoing discussions about what can be relea

Health committee  Yes. We do anticipate doing so in the first two weeks of June, and the committee is very committed to doing this as quickly as possible, understanding the need for provinces and territories to design their programs around this.

Health committee  Maybe I can start, and Iain can chime in. Moderna becomes the workhorse of the portfolio in Q3. There's a big Q3 ramp up. We are waiting for a revised schedule from Moderna, because I think it's been well document that Moderna has hit a bit of a bump in production. We should hav

Health committee  Mr. Chair, it's not clear to me that Moderna has prioritized EU countries. They have, as I mentioned, had some challenges, and they are trying to best serve the various contracts in the best way possible. More than a million doses arrived this week. We're optimistic that we wil

Health committee  Yes. As I mentioned earlier, Canada can give doses to other countries. That is an option.

Health committee  Mr. Chair, just to clarify that, when these contracts were negotiated, these suppliers were effectively experimenting and manufacturing at risk, so when you sign on for doses.... While we have the right to donate them, these doses met the regulatory tests, so they are Canada's to

Health committee  There are opt-out clauses in terms of options, but in terms of the actual initial commitment around doses, they are doses that Canada signed on for.

Health committee  I'm going from memory here, but generally speaking these were very much “at risk contracts”, so the vaccine producers were effectively not interested in allowing for opt-out clauses because they were taking all of the risk in terms of the research, the clinical trials, and then t

Health committee  Thank you for the question. First of all, all contracts have clauses that allow Canada to give the doses to other countries. That is always an option. Almost all contracts include clauses that allow Canada to purchase doses—

Health committee  Is that better? My apologies. We have in place clauses that allow Canada to donate as well as to exercise options, if more doses are allowed. I would underline for members that when these contracts were negotiated. it was uncertain whether the vaccines would work against COVID,